ArticleScientific reports2025
Rapid diagnosis of celiac disease based on serum infrared spectroscopy combined with deep learning.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Celiac disease (CD) and its early-stage variant, potential celiac disease (PCD), pose considerable diagnostic challenges due to their overlapping serological and symptomatic features, and the lack of villous atrophy in PCD. Accurate and non-invasive differentiation between CD, PCD, and healthy controls (HC) is crucial for timely intervention and effective management. In this study, we propose a novel hybrid dual-attention deep learning model for the classification of CD, PCD, and HC using Fourier-transform infrared (FTIR) spectroscopy of serum samples. The proposed model integrates two heterogeneous attention mechanisms in a dual-branch architecture: a self-attention module to capture long-range global dependencies across the spectral dimensions, and a channel-wise attention mechanism to highlight locally significant spectral features. The fusion of global and local information enables the model to sensitively detect subtle spectral variations associated with PCD and to robustly discriminate it from both CD and HC, which is a significant advancement over conventional methods. Comprehensive experiments demonstrate that our model achieves superior classification performance compared to baseline architectures, with notably improved sensitivity in distinguishing PCD from CD. This framework offers a promising, non-invasive, and interpretable approach for early and precise diagnosis of celiac spectrum disorders, and may serve as a decision support tool in clinical settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.